Cancer Risk Profiles

Genetic Identification Techniques Yield Clues To Cancer Susceptibility

Published in Cancer Weekly, November 13th, 2001

Human cancer tissue collections and mouse models are bringing scientists closer to identifying genetic markers of human cancer susceptibility that could improve cancer diagnostics, therapeutics, and prevention strategies, according to Allan Balmain, PhD, a leading cancer researcher.

A very strong genetic component exists in the development of human cancers, according to Balmain, Barbara Bakar Bass Professor of Cancer Genetics at the Cancer Research Institute, University of California, San Francisco. "The genetic contribution to risk in prostate cancer is probably at least 40% of the entire risk," Dr. Balmain said. "Unfortunately, 99% of genes that cause this kind of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-11-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry